<DOC>
	<DOCNO>NCT00227344</DOCNO>
	<brief_summary>The objective prospective multicenter randomize study establish effectiveness treatment persistent atrial fibrillation encircle pulmonary vein radiofrequency ( RF ) ablation create additional line block aid NAVISTAR® THERMOCOOL® catheter conjunction CARTO™ EP Navigation System . Effectiveness determine compare chronic success ablation therapy versus antiarrhythmic drug therapy , define absence persistent tachyarrhythmias first 24 month run-in phase 2 month .</brief_summary>
	<brief_title>CACAF2 Study : Catheter Ablation Cure Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>1870 year Written inform consent One document relapse atrial fibrillation ( AF ) antiarrhythmic drug therapy electrical cardioversion Permanent atrial fibrillation Patients try &gt; 1 antiarrhythmic drug ( Class I Class III ) . AF sole rhythm &gt; 6 month enrollment . Previous ablation AF . AF deem secondary transient correctable abnormality include electrolyte imbalance , trauma , recent surgery , infection , toxic ingestion , endocrinopathy . Patients fibrillation episode trigger another uniform arrhythmia ( eg , atrial flutter atrial tachycardia ) . Patients intraatrial thrombus , tumor , another abnormality preclude catheter introduction . Patients WolfParkinsonWhite syndrome . Patients await cardiac transplantation . Congestive heart failure ( CHF ) New York Heart Association ( NYHA ) Class IIIIIIV ejection fraction ( EF ) &lt; 40 % . Patients unstable angina acute myocardial infarction within 3 month . Patients cardiac revascularization cardiac surgery within 6 month . Patients heart disease corrective surgery anticipate . Patients appropriate vascular access preclude . Pregnant woman . A separate requirement antiarrhythmic drug treatment , require antiarrhythmic drug previously try AF suppression . Prior atrial surgery . Contraindication treatment warfarin bleed diathesis . Renal failure require dialysis . Hepatic failure . Participant investigational clinical device trial . Unwilling unable give inform consent . Inaccessible followup . Psychological problem might limit compliance . Active abuse alcohol drug may causative AF . An implanted device ( pacemaker cardioverterdefibrillator ) . Left atrial diameter ( anteroposterior ) &gt; 50 mm .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>